Cyclopharm (ASX:CYC) has announced that Technegas received Pass-Through status from the US Centre for Medicare and Medicade Services …
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 6 November
November 6, 2026 - - Podcast -
Omico names laboratory partners to expand genomic profiling for Australians with cancer
November 6, 2026 - - Latest News -
Marie Guillet joins the European Australian Business Council board
November 6, 2026 - - Latest News -
The next agreements must end the culture of enforced silence
November 6, 2026 - - Latest News -
The lessons we can take from 'Robodebt' and the Reserve Bank reforms
November 6, 2026 - - Latest News -
Vaccines dominate public health spending but prevention investment slips
November 5, 2026 - - Latest News -
Increased accountability can be the only response to expanding authority
November 5, 2026 - - Latest News